Hahn testifies on Covid-19 response, says FDA on target to hit user fee goals
FDA commissioner Stephen Hahn on Tuesday testified before the House Energy and Commerce Committee on his agency’s response to the coronavirus disease (Covid-19) pandemic.
User fee goals, policy review
Despite an “incredible surge in volume” of applications and constraints on the agency’s ability to conduct inspections, Hahn said that the FDA “has maintained the same pace of meeting its goals on applications for medical products for the last six months that is has maintained in recent years.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.